Trial Profile

A Phase IIa study of OPM-201 in patients with Parkinson's disease

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 06 Apr 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

03 Mar 2026 The According to Oncodesign media release, current grant supports the CMC work related to the preparation of Drug Product (drug tablets to be used in the studies) for the Phase 1b and the start of Phase 2 studies, starting from the available 67 kgs of GMP Drug Substance (the pure OPM-201 chemical material).
03 Mar 2026 According to Oncodesign Precision Medicine media release, this trial is expected to began in 2027.
03 Apr 2024 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com